KORU Medical Systems, Inc. (KRMD) Income Statement
KRMD 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsKRMD revenue and net income
Where KRMD's revenue goes
2025Each bar shows an amount and its share of revenue. KRMD kept −6.4% of revenue as net income.
KRMD profit margins
KRMD growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +22.2% | +13.8% | +11.2% | +12.9% |
| Gross profit | +20.0% | +18.5% | +11.4% | +12.9% |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
KRMD quarterly EPS vs estimates
KORU Medical Systems beat the analyst EPS estimate in 7 of the last 8 quarters. Next report: November 11, 2026 (estimate $0.00).
KRMD income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41.1M | $33.6M | $28.5M | $27.9M | $23.5M | $24.2M | $23.2M | $17.4M | $16.0M | $12.3M |
| Cost of revenue | $15.5M | $12.3M | $11.8M | $12.5M | $9.7M | $9.2M | $8.3M | $6.5M | $6.5M | $4.7M |
| Gross profit | $25.6M | $21.3M | $16.7M | $15.4M | $13.8M | $14.9M | $14.9M | $10.8M | $9.5M | $7.6M |
| Research & development | $4.4M | $5.3M | $5.7M | $5.0M | $2.5M | $1.3M | $740,475 | $241,124 | $60,704 | $237,486 |
| Sales, general & admin | $23.4M | $21.6M | $20.4M | $20.6M | $17.9M | $12.0M | $9.8M | $9.1M | $7.7M | $7.8M |
| Total operating expenses | $28.6M | $27.8M | $27.0M | $26.1M | $20.8M | $16.2M | $10.9M | $8.7M | $8.0M | $8.3M |
| Operating income | −$3.0M | −$6.4M | −$10.3M | −$10.8M | −$7.0M | −$1.3M | $585,679 | $1.2M | $1.5M | −$736,251 |
| Interest income | $293,403 | $444,642 | $561,328 | $145,587 | $13,083 | $42,395 | $80,663 | $28,104 | $3,743 | $2,937 |
| Interest expense | — | — | — | $145,587 | $637,198 | $4.8M | $6.7M | $3,276 | $65,651 | $1,886 |
| Income before taxes | −$2.6M | −$6.1M | −$9.8M | −$10.7M | −$6.4M | −$1.2M | $696,418 | $1.2M | $1.6M | −$776,699 |
| Income taxes | $21,890 | $2,893 | $4.0M | −$2.0M | −$1.8M | $17,800 | $132,069 | $266,380 | $483,075 | −$241,700 |
| Net income | −$2.6M | −$6.1M | −$13.7M | −$8.7M | −$4.6M | −$1.2M | $564,349 | $910,570 | $1.1M | −$535,000 |
| EBITDA | −$1.8M | −$5.2M | −$8.9M | −$10.1M | −$5.9M | $1.6M | $4.3M | $2.4M | $1.9M | −$474,202 |
| EPS (diluted) | −$0.03 | −$0.07 | −$0.16 | −$0.18 | −$0.09 | $0.03 | $0.10 | $0.06 | $0.01 | −$0.01 |
| Gross margin | 62.3% | 63.4% | 58.6% | 55.1% | 58.6% | 61.8% | 64.1% | 62.3% | 59.2% | 61.6% |
| Operating margin | −7.2% | −19.2% | −36.0% | −38.6% | −29.9% | −5.2% | 2.5% | 6.7% | 9.3% | −6.0% |
| Net margin | −6.4% | −18.0% | −48.2% | −31.0% | −19.4% | −5.0% | 2.4% | 5.2% | 6.8% | −4.4% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.0M | $11.8M | $10.9M | $10.4M | $10.2M | $9.6M | $8.8M | $8.2M | $8.4M | $8.2M | $7.2M | $7.0M |
| Cost of revenue | $4.2M | $4.7M | $4.1M | $4.1M | $3.7M | $3.6M | $3.3M | $3.0M | $3.0M | $3.1M | $2.9M | $2.7M |
| Gross profit | $7.8M | $7.0M | $6.8M | $6.3M | $6.5M | $6.0M | $5.6M | $5.2M | $5.5M | $5.1M | $4.3M | $4.3M |
| Research & development | $1.1M | $1.3M | $1.1M | $933,107 | $1.2M | $1.1M | $1.1M | $1.5M | $1.1M | $1.5M | $1.3M | $1.3M |
| Sales, general & admin | $5.9M | $6.6M | $6.0M | $6.0M | $5.4M | $6.0M | $5.8M | $5.1M | $5.3M | $5.4M | $5.0M | $4.6M |
| Total operating expenses | $7.2M | $7.9M | $7.4M | $7.1M | $6.8M | $7.3M | $7.2M | $6.9M | $6.7M | $7.1M | $6.5M | $6.1M |
| Operating income | $626,991 | −$864,923 | −$547,104 | −$867,679 | −$312,655 | −$1.2M | −$1.6M | −$1.7M | −$1.2M | −$2.0M | −$2.2M | −$1.8M |
| Interest income | $59,870 | $80,995 | $66,705 | $74,567 | $78,951 | $73,180 | $80,459 | $112,995 | $213,999 | $37,187 | $169,230 | $135,429 |
| Income before taxes | $258,249 | −$807,078 | −$482,172 | −$778,116 | −$189,511 | −$1.2M | −$1.6M | −$1.6M | −$988,715 | −$1.9M | −$2.0M | −$1.7M |
| Income taxes | $5,800 | — | $4,684 | −$150 | $17,356 | — | $2,893 | — | −$4 | $188,094 | $5.4M | −$300,247 |
| Net income | $252,449 | −$807,078 | −$486,856 | −$777,966 | −$206,867 | −$1.2M | −$1.6M | −$1.6M | −$988,715 | −$1.9M | −$7.5M | −$1.4M |
| EBITDA | $468,279 | −$609,547 | −$302,998 | −$573,634 | $19,976 | −$948,880 | −$1.4M | −$1.4M | −$770,852 | −$1.7M | −$1.8M | −$1.5M |
| EPS (diluted) | $0.01 | −$0.02 | $0.01 | −$0.02 | $0.01 | −$0.03 | −$0.03 | −$0.01 | −$0.01 | −$0.02 | −$0.03 | −$0.03 |
| Gross margin | 65.1% | 59.8% | 62.6% | 60.2% | 63.5% | 62.8% | 62.9% | 63.4% | 65.0% | 62.3% | 60.3% | 62.0% |
| Operating margin | 5.2% | −7.4% | −5.0% | −8.3% | −3.1% | −12.9% | −18.0% | −20.8% | −14.1% | −23.9% | −30.6% | −25.6% |
| Net margin | 2.1% | −6.9% | −4.5% | −7.5% | −2.0% | −12.1% | −17.7% | −19.3% | −11.7% | −23.6% | −103.9% | −19.5% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in KRMD's financial statements (latest annual report filed March 12, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
KRMD financial results
In fiscal year 2025 (ended December 31, 2025), KORU Medical Systems reported revenue of $41.1 million, up 22.2% from the year before. It had a net loss of $2.6 million, a net profit margin of −6.4%. Diluted earnings per share came to −$0.03. Over five years revenue grew at an average rate of 11.2% a year.
See the KRMD stock overview for the latest quote and news, or the KRMD chart for price history and technical indicators.
KRMD income statement FAQ
What is KORU Medical Systems's annual revenue?
KORU Medical Systems reported total revenue of $41.1 million for fiscal year 2025, which ended on December 31, 2025. That was up 22.2% from $33.6 million the previous year.
Is KORU Medical Systems profitable?
No. KORU Medical Systems reported a net loss of $2.6 million in fiscal 2025, a net profit margin of −6.4%; its operating margin was −7.2%.
What is KORU Medical Systems's gross margin?
KORU Medical Systems's gross margin was 62.3% in fiscal 2025: for every $100 of revenue, KORU Medical Systems kept $62 after the direct cost of its products and services.
How much does KORU Medical Systems spend on research and development?
KORU Medical Systems spent $4.4 million on research and development in fiscal 2025, 10.7% of revenue.
How fast is KORU Medical Systems growing?
Revenue grew 11.2% a year on average over the last five fiscal years, from $24.2 million to $41.1 million.
What are KORU Medical Systems's earnings per share?
KORU Medical Systems earned $-0.03 per diluted share in fiscal 2025, compared with $-0.07 a year earlier.
When will KORU Medical Systems report its next earnings?
KORU Medical Systems is expected to report results for the quarter ending September 30, 2026 on November 11, 2026 after the market closes.
When does KORU Medical Systems's fiscal year end?
KORU Medical Systems's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 12, 2026.